HomeProductsBuilding BlocksCarbocyclic ScaffoldsNaphthalene CompoundsDapoxetine
Chemical structure of CAS 119356-77-3

Dapoxetine

CAS No.119356-77-3
MDL No.MFCD00865355
MFC21H23NO
MW305.40
InChI KeyUSRHYDPUVLEVMC-FQEVSTJZSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

Dapoxetine is a naphthalene derivative.

CAS No.119356-77-3
Product NameDapoxetine

Biological Targets

SLC6A4

Associated Conditions

sexual dysfunction·premature ejaculation·erectile dysfunction
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Dapoxetine, a novel treatment for premature ejaculation, does not have pharmacokinetic interactions with phosphodiesterase-5 inhibitors.

International journal of impotence research • Vol. 18, Issue 1 • 2006
PMID: 16307008DOI: 10.1038/sj.ijir.3901420

Pharmacokinetic and pharmacodynamic features of dapoxetine, a novel drug for 'on-demand' treatment of premature ejaculation.

BJU international • Vol. 97, Issue 2 • 2006
PMID: 16430636DOI: 10.1111/j.1464-410X.2006.05911.x

Late-stage clinical development in lower urogenital targets: sexual dysfunction.

British journal of pharmacology • Vol. 147 Suppl 2, Issue Suppl 2 • 2006
PMID: 16465180PMC: PMC1751495DOI: 10.1038/sj.bjp.0706638

What's the point?

BJU international • Vol. 97, Issue 3 • 2006
PMID: 16469042DOI: 10.1111/j.1464-410X.2006.06112.x

Documentation

Similar Products